Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.
The initiation of adaptive immunity against pathogens and tumors relies on the ability of dendritic cells to process and present antigens to prime naive T cells. As sentinels of the immune system, ...
Two Northeastern University researchers want to make life better for people who've experienced serious physical trauma, the kind caused by bad car accidents or from injuries sustained during wartime; ...
The Komodo dragon is one of the most dangerous predators on Earth. Instead of relying on speed, it uses patience—delivering a powerful bite and then tracking its prey for days. With an incredible ...
OLYMPIA, Wash. — A proposed bill that prohibits the construction of new isolation rooms in public schools and places strict limits on when staff can physically restrain students is about to become law ...
Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...
The family of Henrietta Lacks has settled its lawsuit against generic drugmaker Viatris, ending another legal fight over the use of Lacks’ cells taken without her consent. Court records show the case ...
Scientists placed 200,000 living human brain cells on a microchip and taught it how to play a doomsday video game — and are now using the dystopian tech to power AI data centers. Australian biotech ...
Democratic lawmakers in Colorado are raising concerns about the extended use of holding cells in Immigration and Customs Enforcement suboffices across the state, but the Department of Homeland ...
Viatris (VTRS) has reached a settlement with the estate of Henrietta Lacks to resolve allegations that the generic drugmaker used Lacks’ cancer cells without her permission to advance its drug ...
March 12 (Reuters) - Generic drugmaker Viatris (VTRS.O), opens new tab has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose tissue samples were used without her ...
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...